Sanara MedTech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.42	16.58	15.88	5.15	8.96	18.65
Cash & Short-Term Investments	15.42	16.58	15.88	5.15	8.96	18.65
Cash Growth	-9.07%	4.41%	208.48%	-42.55%	-51.97%	3996.23%
Accounts Receivable	12.57	12	12.41	8.47	6.81	2.86
Other Receivables	-	-	1.14	0.06	0.2	0.13
Total Trade Receivables	12.57	12	13.55	8.53	7	2.99
Inventory	3.46	3.95	2.75	4.72	3.55	2.05
Other Current Assets	0.75	1.02	1.12	0.61	1.1	0.92
Total Current Assets	32.2	33.54	33.31	19.01	20.62	24.61
Net Property, Plant & Equipment	2.34	2.53	1.88	3.25	2.22	2.04
Other Intangible Assets	17.28	18.64	23.48	44.93	31.51	4.73
Goodwill	3.6	3.6	3.6	3.6	3.6	-
Long-Term Investments	13.73	14.63	6.21	3.08	3.08	5.02
Other Long-Term Assets	-	-	19.61	-	-	-
Total Assets	69.15	72.94	88.09	73.87	61.04	36.4
Accounts Payable	1.4	2.34	1.53	2	1.43	0.59
Accrued Expenses	10.36	14.47	12.35	9.72	9.9	5.23
Current Portion of Long-Term Debt	-	-	-	0.58	-	-
Current Portion of Leases	0.38	0.35	0.36	0.36	0.31	0.2
Other Current Liabilities	0.35	1.47	1.05	1.1	1.16	-
Total Current Liabilities	12.49	18.63	15.29	13.77	12.81	6.02
Long-Term Debt	46.48	45.97	30.69	9.11	-	-
Long-Term Leases	1.67	1.87	1.24	1.74	0.51	0.22
Other Long-Term Liabilities	0.57	0.55	1.96	4.66	6	-
Total Long-Term Liabilities	48.72	48.39	33.89	15.52	6.51	0.22
Total Liabilities	61.21	67.01	49.18	29.28	19.32	6.24
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	82.83	81.23	77.18	72.86	65.21	45.87
Retained Earnings	-74.89	-75.3	-37.78	-28.04	-23.39	-15.24
Total Common Shareholders' Equity	7.94	5.94	39.4	44.83	41.83	30.64
Shareholders' Equity	7.93	5.93	38.91	44.59	41.72	30.15
Total Liabilities & Equity	69.15	72.94	88.09	73.87	61.04	36.4
Total Debt	48.53	48.19	32.29	11.79	0.82	0.43
Net Cash (Debt)	-33.11	-31.61	-16.41	-6.64	8.14	18.23
Net Cash Growth	-	-	-	-	-55.34%	-
Net Cash Per Share	-3.78	-3.67	-1.93	-0.80	1.03	2.48
Book Value	7.94	5.94	39.4	44.83	41.83	30.64
Book Value Per Share	0.91	0.69	4.64	5.42	5.29	4.17
Tangible Book Value	-12.94	-16.3	12.32	-3.7	6.72	25.91
Tangible Book Value Per Share	-1.48	-1.89	1.45	-0.45	0.85	3.53

SEC Filings: 10-K · 10-Q